Conviction
$ Value
$224K
Shares
48,000
Price
$5
Filed
Feb 27
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Phanstiel S. Louise
Title
—
CIK
0001471518
Roles
Transaction Details
Transaction Date
2026-02-27
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
281,951
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.725 to $4.75, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.71 to $5.01, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.79, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Phanstiel S. Louise's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | MYGN | ▲ | $224K |
| 2026-02-26 | MYGN | ▲ | $242K |
| 2026-02-25 | MYGN | ▲ | $29K |
| 2025-12-15 | BFLY | ▲ | $571K ★ |
| 2025-06-13 | BFLY | A | $0 |
| 2025-06-05 | MYGN | A | $0 |
Other Insiders at MYGN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Phanstiel S. Louise | $271K | — | 2026-02-26 |
|
Raha Samraat S.
President and CEO
|
$200K | — | 2026-03-09 |
|
Solaiman Shereen
Chief People Officer
|
— | — | 2026-03-01 |
|
Verratti Mark
Chief Operating Officer
|
— | — | 2026-04-14 |
|
Haas Kevin Richard
Chief Technology Officer
|
— | — | 2026-02-02 |
|
Muzzey Dale
Chief Scientific Officer
|
— | — | 2026-04-14 |
|
Wheeler Benjamin Richard
Chief Financial Officer
|
— | — | 2026-02-02 |